Accretion Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 73.52% of Accretion Pharmaceuticals, FIIs hold 0.17%, DIIs hold 3.65% and the public holds 22.66%. Promoter holding was unchanged from Jun 2026.
Get an alert when Accretion Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
73.52%
unchanged QoQ
FIIs
0.17%
+0.17 pp QoQ
DIIs
3.65%
+0.89 pp QoQ
Public
22.66%
−1.06 pp QoQ
Accretion Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 73.52% | 0.17% | 3.65% | 22.66% | 719 |
| Jun 2026 | 73.52% | 0.00% | 2.76% | 23.72% | 776 |
| Mar 2026 | 73.52% | 0.00% | 0.00% | 26.48% | 1,182 |
| Dec 2025 | 73.52% | 0.00% | 0.00% | 26.48% | 1,179 |
| Sep 2025 | 73.52% | 1.16% | 0.00% | 25.33% | 1,498 |
| Jun 2025 | 73.50% | 2.22% | 0.09% | 24.19% | 1,628 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹233 cr, the promoter group's 73.52% stake is worth ₹172 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Accretion Pharmaceuticals shareholding: common questions
What is the promoter holding in Accretion Pharmaceuticals?
Promoters hold 73.52% of Accretion Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Accretion Pharmaceuticals?
Foreign institutional investors (FIIs) held 0.17% of Accretion Pharmaceuticals in Sep 2026, +0.17 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Accretion Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 3.65% of Accretion Pharmaceuticals in Sep 2026, +0.89 pp versus Jun 2026.
Is the promoter holding in Accretion Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Accretion Pharmaceuticals.
How has Accretion Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 73.52% in Sep 2025 to 73.52% in Sep 2026 (unchanged).
How many shareholders does Accretion Pharmaceuticals have?
Accretion Pharmaceuticals had 719 shareholders in Sep 2026, compared with 776 in Jun 2026.